The purpose of this study is to investigate the time course of PF-00241939 concentrations in the blood following dosing by oral inhalation using dry powder inhalers.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
36
PF-00241939 750ug using inhaler A
PF-00241939 750ug using inhaler B
Pfizer Investigational Site
Singapore, Singapore
Plasma pharmacokinetic parameters: AUClast & Cmax.
Time frame: 48 hours
Plasma pharmacokinetic parameters: AUC0-12, AUC0-24, AUCinf, Tmax and t½.
Time frame: 48 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.